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INTRODUCTION
Burden of Periprosthetic Joint Infection and its Treatment on 
Kidney Function 
Pouya Alijanipour MD, Snir Heller MD, Camilo Restrepo MD, Collin Ackerman BS, Edward J. Filippone MD, William J. Hozack MD.
Investigation performed at the Rothman Institute at Thomas Jeerson University, Philadelphia, PA.
MATERIALS AND METHODS
DISCUSSION
REFERENCES
Table 1. Distribution of kidney injury as dened by the RIFLE criteria in PJI and aseptic groups.
PJI=Periprosthetic joint infection; Cr=Creatinine.
 Patients with periprosthetic joint infection (PJI) are subjected to several potentially 
nephrotoxic conditions such as acute and chronic systemic inammatory reactions, mul-
tiple surgical procedures and noxious antibiotics. This study aims to investigate 1) the in-
cidence and severity of kidney injury in patients undergoing surgical treatment for PJI, 2) 
whether the number of surgeries aects renal function in PJI patients and 3) the potential 
risk factors for kidney injury.
 We retrospectively collected data on 3185 consecutive patients who underwent revi-
sion arthroplasty due to PJI (282) or aseptic (2903) failure during 2000-2011. Baseline and 
postoperative serum creatinine (Cr) levels were used to dene kidney injury, based on 
the RIFLE (Risk, Injury, Failure, Loss and End-stage kidney disease) criteria and clinically 
important minimum rise in serum Cr level (>0.3 mg/dl)1.  Patients with preexisting renal 
disease (baseline Cr level >1.2 mg/dl) were excluded. PJI was dened using criteria re-
cently proposed by International Consensus Group on PJI2.
 The risk of sustaining clinically signicant kidney injury in patients with PJI who un-
dergo revision surgery is increased compared with patients undergoing aseptic revision 
arthroplasty. This dierence does not seem to be fully explained by the increased 
number of surgical procedures in PJI patients. Increased need for intraoperative volume 
repletion due to blood loss and intravenous vancomycin administration are signicant 
risk factors for acute kidney injury following septic revision surgery. Recognition of po-
tential risk factors for such adverse eect should lead to implementation of appropriate 
nephron-protective strategies, such as adequate intraoperative hydration and meticu-
lous adjustment of postoperative vancomycin dosage, in PJI patients.
1. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup. Acute renal 
 failure - denition, outcome measures, animal models, uid therapy and information technology needs: the Second 
 International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care Lond Engl. 
 2004;8(4).
2.  Parvizi J, Gehrke T; International Consensus Group on Periprosthetic Joint Infection. J Arthroplasty. 2014 Jul;29(7):1331.
DISCUSSION
FIGURES 1, 2 & 3
TABLE 1
 Based on the mean of the three highest creatinine values, the incidence of kidney 
injury in PJI and aseptic groups was 26% (72/282) and 7% (98/2903), respectively 
(p<0.001). The distribution of RIFLE criteria is demonstrated in the table 1. Based on the 
nal post-treatment Cr values, the incidence of clinically important minimum rise in Cr 
level was signicantly higher in PJI group (65/282, 23%) compared to aseptic group 
(153/2903, 5%; p <0.001). There was weak trend for the inuence of number of surgeries 
on the incidence of post-treatment residual kidney injury (Spearman’s rho= 0.13, 
p=0.03). In multivariate analysis, accumulative intravenous vancomycin dosage (p<0.01), 
intraoperative volume repletion (p=0.049), and estimated blood loss (p=0.08) were asso-
ciated with RIFLE classication (Figures 1-3). The demographic factors, Charlson comor-
bidity index, use of spacer, duration of surgery, perioperative anemia, transfusion, antico-
agulation method and implant type (cemented versus non-cemented) did not have any 
association.
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N0 kidney damage 210 2805
Risk
Serum Cr > × 1.5 baseline Cr
39 79
Injury
Serum Cr > × 2 baseline Cr
21 17
Failure
Serum Cr > × 3 baseline Cr
10 2
Loss
Complete loss of function > 4 weeks
2 0
End-stage
End-stage kidney disease > 3 months
0 0
Total 282 2903
